Defence Minister Khawaja Asif has strongly criticised Indian Prime Minister Narendra Modi, saying his policies have harmed ...

In a meeting with US Acting Coordinator for Counterterrorism Gregory LoGerfo, Federal Interior Minister Mohsin Naqvi on ...

Quetta: The Baloch Liberation Army (BLA) on Friday denounced the recent decision by the United States to designate its ...

Savara (SVRA) stock was upgraded to Buy at H.C. Wainwright, citing higher prospects for a resubmitted marketing application ...

Q2 2025 Earnings Call Transcript August 14, 2025Brainstorm Cell Therapeutics Inc. beats earnings expectations.

Rocket Pharmaceuticals refocuses on late-stage AAV cardiovascular therapies while cutting costs. Read here for more on RCKT ...

The Baloch Liberation Army (BLA) has rejected the United States' decision to classify its unit, the Majeed Brigade, as a ...

Leadership and talent actions -- Lisa Wolf confirmed as CFO; key hires from Statera joined for regulatory, clinical, and ...

WALTHAM, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced financial results for the quarter ended June 30, 2025, and provided recent business highlights.

Presented positive results from the phase 3 randomized, placebo-controlled clinical trial of CAN-2409 (aglatimagene besadenovec) in localized prostate cancer, during an oral presentation at the 2025 ...

GAAP EPS loss of $0.41 in Q2 2025 beat analyst expectations for a larger loss of $0.48 per share. R&D expenses (GAAP) rose 19% to $23.4 million in Q2 2025 compared to Q2 2024, primarily due to higher ...